These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 1658986)

  • 1. Restoration of nerve agent impaired neuromuscular transmission in rat diaphragm by bispyridinium non-oximes - Structure-activity relationships.
    Amend N; Timperley CM; Bird M; Green AC; Worek F; Seeger T
    Toxicology; 2024 Mar; 503():153741. PubMed ID: 38311098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of bispyridinium non-oxime analogues for the restoration of nerve agent impaired neuromuscular transmission in rat hemidiaphragms - Structure optimization.
    Amend N; Timperley CM; Bird M; Green AC; Worek F; Seeger T
    Toxicol Lett; 2024 Jun; 397():42-47. PubMed ID: 38723915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of organophosphate poisoning in pigs: antidote administration by a new binary autoinjector.
    Göransson-Nyberg A; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Persson SA
    Arch Toxicol; 1995; 70(1):20-7. PubMed ID: 8750901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-reactivating effects of HI-6 on hippocampal neurotransmission.
    Melchers BP; van der Laaken AL; Busker RW; Bruijnzeel PL; Van Helden HP
    Arch Toxicol; 1994; 69(2):118-26. PubMed ID: 7717860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of oximes: how relevant are they?
    van Helden HP; Busker RW; Melchers BP; Bruijnzeel PL
    Arch Toxicol; 1996; 70(12):779-86. PubMed ID: 8911635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
    Antonijevic B; Stojiljkovic MP
    Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.
    van Helden HP; van der Wiel HJ; Zijlstra JJ; Melchers BP; Busker RW
    Arch Toxicol; 1994; 68(4):224-30. PubMed ID: 8067894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
    Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation.
    van Helden HP; de Lange J; Busker RW; Melchers BP
    Arch Toxicol; 1991; 65(7):586-93. PubMed ID: 1664202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organophosphate poisoning: a method to test therapeutic effects of oximes other than acetylcholinesterase reactivation in the rat.
    Busker RW; Zijlstra JJ; van der Wiel HJ; Melchers BP; van Helden HP
    Toxicology; 1991; 69(3):331-44. PubMed ID: 1658986
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.